Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aligos Therapeutics Inc (ALGS)

Aligos Therapeutics Inc (ALGS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aligos Therapeutics Inc ONE CORPORATE DR. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 USA

www.aligos.com Employees: 66 P: 800-466-6059

Description:

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company. It is focused on the development of antiviral therapies for chronic hepatitis B and coronaviruses as well as liver diseases. Aligos Therapeutics, Inc. is based in SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 585,825
Enterprise Value, $K 450,055
Shares Outstanding, K 78,110
Annual Sales, $ 15,530 K
Annual Net Income, $ -87,680 K
Last Quarter Sales, $ 1,060 K
Last Quarter Net Income, $ 5,060 K
EBIT, $ -93,530 K
EBITDA, $ -90,880 K
60-Month Beta 2.16
% of Insider Shareholders 16.50%
% of Institutional Shareholders 60.43%
Float, K 65,222
% Float 83.50%
Short Volume Ratio 0.54

Growth:

1-Year Return -61.92%
3-Year Return -98.16%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.75 on 08/06/24
Next Earnings Date 11/07/24
Earnings Per Share ttm -20.50
EPS Growth vs. Prev Qtr 113.64%
EPS Growth vs. Prev Year 106.98%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 08/19/24

ALGS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -110.59%
Return-on-Assets % -63.90%
Profit Margin % -564.58%
Debt/Equity 0.00
Price/Sales 1.68
Price/Cash Flow N/A
Price/Book 0.39
Book Value/Share 21.08
Interest Coverage -1.84
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar